drugset / Trial / NCT03396523

Losartan and Emotion Processing

NCT03396523

RandomizedParallel-groupDouble-blindBasic science

Summary

The aim of the study is to investigate the effect of losartan (50mg, single dose) on the extinction of conditioned fear

Timeline

Start
2018-01-04
Primary completion
2018-10-31
Completion
2018-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Losartan Other / unclassified 50 mg Oral

Indications

No indication recorded.